Research Grants show all

NIH12

Patents show all

23Applications13Issued

Clinical Trials show all

6N/A

SEC Filings show all

D5

SEC Form D Funding Events

DateOfferedSoldType
2013-06-11$1,285,997$1,285,997Equity
2010-06-28$1,003,750$1,003,750Equity, Option to Acquire

Key Executives

  • William F Walker
    Executive Officer, Director
  • Francesco Viola
    Executive Officer
  • Michael B Laurence
    Executive Officer
  • Matt Hantzmon
    Director
  • Jonathan Sackier
    Director
  • Mark Wheeler
    Director
  • David Freed
    Director